Role of Pentoxifylline and Sparfloxacin in Prophylaxis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients

Table 2

Selected clinical and laboratory features of patients at baseline.

Parameters	Group 1	Group 2	Group 3	Group 4	𝑃 value
AST (IU/L)	74.1 ± 16.23	78.1 ± 10.65	75.80 ± 11.47	78.10 ± 10.58	0.838
ALT (IU/L)	52.40 ± 14.27	54.40 ± 11.62	50.10 ± 10.68	49.8 ± 8.84	0.664
BIL-T (mg/dL)	2.46 ± 0.90	2.72 ± 0.77	2.57 ± 0.49	2.16 ± 0.71	0.412
BIL-D (mg/dL)	1.11 ± 0.37	1.31 ± 0.44	1.27 ± 0.44	1.21 ± 0.26	0.690
Albumin (g/dL)	2.55 ± 0.37	2.75 ± 0.35	2.60 ± 0.38	2.52 ± 0.34	0.970
PT (Sec.)	28.4 ± 6.70	28.0 ± 5.52	28.1 ± 4.33	27.6 ± 2.07	0.980
BUN (mg/dL)	71.0 ± 20.83	71.6 ± 20.94	71.4 ± 17.21	70.00 ± 11.81	0.992
s.Cr (mg/dL)	1.51 ± 0.35	1.48 ± 0.30	1.47 ± 0.35	1.56 ± 0.31	0.820
Sodium (mEq/L)	124.30 ± 6.85	126.5 ± 3.84	127.60 ± 5.78	128.1 ± 4.58	0.286
Hemoglobin (g/dL)	9.11 ± 0.92	9.03 ± 1.16	8.71 ± 0.97	8.75 ± 0.62	0.589
RBCs (10^6/uL)	3.22 ± 0.51	3.39 ± 0.43	3.26 ± 0.41	3.31 ± 0.25	0.795
WBCs (10^3/uL)	8.72 ± 1.70	8.95 ± 1.39	9.12 ± 1.34	9.23 ± 1.35	0.875
Platelets (10^3/uL)	77.04 ± 17.75	77.76 ± 8.75	77.76 ± 14.27	78.39 ± 11.17	0.795
TNF-𝛼 (pg/mL)	128.17 ± 28.63	113.37 ± 17.54	117.78 ± 22.03	115.38 ± 22.21	0.49

Data presented by mean ± SD; AST: aspartate transaminase; ALT: alanine aminotransferase; BIL-T: total bilirubin; BIL-D: direct bilirubin; PT: prothrombin time; BUN: blood urea nitrogen; s.Cr: serum creatinine; RBCs: red blood cells; WBCs: white blood cells; TNF-𝛼: tumor necrosis factor alpha; pg/mL: picograms per milliliter.